FibroBiologics, Inc.
FBLG
$0.26
-$0.02-5.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.24M | -5.78M | -4.66M | -4.97M | -3.10M |
| Total Depreciation and Amortization | 234.00K | 231.00K | 206.00K | 161.00K | 153.00K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 625.00K | -- | -- |
| Total Other Non-Cash Items | 1.18M | 1.52M | 322.00K | 1.09M | 152.00K |
| Change in Net Operating Assets | -1.34M | 58.00K | -479.00K | -1.56M | -279.00K |
| Cash from Operations | -3.16M | -3.97M | -3.98M | -5.28M | -3.07M |
| Capital Expenditure | 0.00 | -6.00K | -213.00K | -43.00K | -99.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -6.00K | -213.00K | -43.00K | -99.00K |
| Total Debt Issued | 0.00 | 0.00 | 4.38M | -- | 9.40M |
| Total Debt Repaid | -3.40M | -- | -- | -- | -115.00K |
| Issuance of Common Stock | 6.59M | -- | -- | -- | 45.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.19M | 0.00 | 4.38M | -- | 9.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.00K | -3.98M | 178.00K | -5.32M | 6.16M |